Longbio Pharma: Clinical Trials

2 trials sponsored by Longbio Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Active not recruiting 1, Not yet recruiting 1

Follow Longbio Pharma: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Spontaneous Urticaria Who Remain Symptomatic Despite Treatment With H1 Antihistamines
LP-003 Injection, Omalizumab - Chronic Spontaneous Urticaria (CSU)
Phase 3Not yet recruitingLongbio Pharma5142026-12-072026-11-18
Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis
LP-003, Placebo - Seasonal Allergic Rhinitis
Phase 3Active not recruitingLongbio Pharma5462024-08-012025-12-26

Conditions studied

Chronic Urticaria (1)  ·  Rhinitis, Allergic, Seasonal (1)

Interventions

Omalizumab (1)

Countries

China (2)

Top investigators

Xinghua Gao (1)  ·  Xueyan Wang (1)